Trials / Recruiting
RecruitingNCT06635538
One-shot Ovarian Stimulation Protocol (One-shot)
One-Shot Ovarian Stimulation Protocol: A Pilot Study Investigating the Endocrine Profile
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Fundación Santiago Dexeus Font · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The current prospective observational pilot study aims to evaluate the endocrine profile of a single-injection protocol (single CFA + daily oral administration of CC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Corifollitropin alfa (CFA) 150 mcg + Clomiphene Citrate (CC) 100 mg/day from D1 | On day 2 or 3 of the menstrual cycle or after 5 days of pill-free interval, a single injection of 150 mcg of CFA (Stimulation Day 1) will be administered. |
| DRUG | Clomiphene Citrate (CC) 100 mg/day from D1 | On day 2 or 3 of the menstrual cycle or after 5 days of pill-free interval, the patients will start oral administration of Clomiphene Citrate 100/day continuing up to and including the day of ovulation triggering |
| DIAGNOSTIC_TEST | Monitoring cycle | Scan controls and blood exams will be performed on stimulation days 1, 6, 8, 10 and, according to clinical needs, until trigger day. |
Timeline
- Start date
- 2024-10-31
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
- First posted
- 2024-10-10
- Last updated
- 2025-02-26
Locations
3 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT06635538. Inclusion in this directory is not an endorsement.